Stephanie C. Kroeze
Aarau, AG, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Adverse Events After Metastases-Directed Stereotactic Radiotherapy and Biological Cancer Therapy.
Journal: JAMA network open
Published: January 14, 2026
ESMO-ESTRO consensus statements on the safety of combining radiotherapy with CDK4/6, HER2, PARP, or mTOR inhibitors.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: November 25, 2025
PSA persistence in the PSMA PET era: reassessing a risk factor after radical prostatectomy.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: October 09, 2025
ESMO-ESTRO framework for assessing the interactions and safety of combining radiotherapy with targeted cancer therapies or immunotherapy.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: April 16, 2025
An international and multidisciplinary EORTC survey on resectability of stage III non-small cell lung cancer.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: September 07, 2024
Better Oncological Outcomes After Prostate-specific Membrane Antigen Positron Emission Tomography-guided Salvage Radiotherapy Following Prostatectomy.
Journal: European urology focus
Published: May 26, 2024
Whole pelvis vs. hemi pelvis elective nodal radiotherapy in patients with PSMA-positive nodal recurrence after radical prostatectomy - a retrospective multi-institutional propensity score analysis.
Journal: European journal of nuclear medicine and molecular imaging
Published: March 13, 2024
European association of urology risk stratification predicts outcome in patients receiving PSMA-PET-planned salvage radiotherapy for biochemical recurrence following radical prostatectomy.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: February 03, 2024
Multi-institutional Analysis of Metastasis-directed Therapy with or Without Androgen Deprivation Therapy in Oligometastatic Castration-sensitive Prostate Cancer.
Journal: European urology oncology
Published: December 21, 2023
Interdisciplinary Swiss consensus recommendations on staging and treatment of advanced prostate cancer.
Journal: Swiss medical weekly
Published: August 20, 2023
The prognostic significance of a negative PSMA-PET scan prior to salvage radiotherapy following radical prostatectomy.
Journal: European journal of nuclear medicine and molecular imaging
Published: August 06, 2023
Can PSMA PET/CT help in dose-tailoring in post-prostatectomy radiotherapy?
Journal: Frontiers in oncology
Published: July 27, 2023
Last Updated: 09/26/2026